Giovannni Palladini

51PUBLICATIONS
217CO-AUTHORS
Major global burdens of diseaseGene and molecular therapyAutoimmunityCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (51)

|Oct 22, 2026
Outcomes of Patients With AL Amyloidosis and End-Stage Renal Disease After Initiation of Therapy.

|Oct 07, 2026
Neurologic Stability During Tafamidis Treatment in Transthyretin Amyloidosis with a Mixed Phenotype: A Multicenter Real-World Study.

|Jun 17, 2026
Unveiling the unseen: navigating heart involvement in amyloidosis with biomarkers beyond the horizons of imaging.

|Jun 15, 2026
A phase 2 trial of daratumumab monotherapy for patients with newly diagnosed cardiac stage IIIb AL amyloidosis.

|May 12, 2026
Daratumumab-bortezomib-cyclophosphamide-dexamethasone for newly diagnosed amyloidosis: ANDROMEDA final survival analysis.

|Mar 12, 2026
Blood phosphorylated tau elevation as a biomarker in immunoglobulin light chain and transthyretin amyloidosis.

Stephan A Kaeser, Stephanie A Schultz, Anna Hofmann

Pageof 9

Frequent Collaborators

25 joint publications

Giampaolo Merlini

15 joint publications

Paolo Milani

11 joint publications

Efstathios Kastritis

10 joint publications

Mario Nuvolone